Correlation Between ACELYRIN, INC and Palisade Bio

Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and Palisade Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and Palisade Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ACELYRIN, INC Common and Palisade Bio, you can compare the effects of market volatilities on ACELYRIN, INC and Palisade Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of Palisade Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and Palisade Bio.

Diversification Opportunities for ACELYRIN, INC and Palisade Bio

0.75

Correlation Coefficient

ACELYRIN, INC  Palisade Bio

Poor diversification

The 3 months correlation between ACELYRIN, and Palisade is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and Palisade Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palisade Bio and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with Palisade Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palisade Bio has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and Palisade Bio go up and down completely randomly.

Pair Corralation between ACELYRIN, INC and Palisade Bio

Given the investment horizon of 90 days ACELYRIN, INC Common is expected to under-perform the Palisade Bio. But the stock apears to be less risky and, when comparing its historical volatility, ACELYRIN, INC Common is 1.7 times less risky than Palisade Bio. The stock trades about -0.03 of its potential returns per unit of risk. The Palisade Bio is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  4,260  in Palisade Bio on September 30, 2024 and sell it today you would lose (4,093) from holding Palisade Bio or give up 96.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	83.9%
Values	Daily Returns

ACELYRIN, INC Common  vs.  Palisade Bio

ACELYRIN, INC Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ACELYRIN, INC Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Palisade Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Palisade Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with ACELYRIN, INC and Palisade Bio

The main advantage of trading using opposite ACELYRIN, INC and Palisade Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, Palisade Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will offset losses from the drop in Palisade Bio's long position.

The idea behind ACELYRIN, INC Common and Palisade Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.